A list of downloadable documents created during development.
Final appraisal determination
Consultation documents published: - scope consultation
Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib: draft scope (rescope)
Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib: draft matrix (rescope)
Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib: draft scope
Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib: draft matrix